DoW Peer Reviewed Medical, Platform Clinical Translation Award
This grant funds up to $15M for multi-PI teams to develop and translate clinical technologies addressing urgent military health needs in two FY26 topic areas, requiring patient advocate involvement and up to 4 years of support.
Funder: Dept. of the Army -- USAMRAA
Due Dates: July 23, 2026: Pre-Application (Preproposal) | September 22, 2026: Full Application | September 30, 2026: End of Application Verification
Funding Amounts: ~$30M total; up to $15M per award (max 4 years); ~$8M available FY26, remainder contingent on future funds.
Summary: Supports translational development and/or early-phase clinical trials of platform clinical technologies addressing two FY26 PRMRP topic areas relevant to military health.
Key Information: Requires multi-topic alignment, milestone-driven research, and an advisory board with patient advocate.
Description
This opportunity supports the translational development and/or early-phase clinical trials of broadly applicable platform clinical technologies that address urgent and complex medical needs relevant to two congressionally directed FY26 Peer Reviewed Medical Research Program (PRMRP) topic areas. The goal is to advance platform products—defined as tangible or knowledge products with potential to improve clinical care for multiple conditions—aligned with PRMRP strategic goals and the health needs of military Service Members, Veterans, and their families. Projects may include both preclinical and early clinical work, must be milestone-driven, and require an external advisory board with patient advocate participation.
